Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F069 - The Science of Cosmeceuticals and Nutraceuticals

Saturday, February 17; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize current trends in cosmeceutical formulation and use.
  • Assess theories regarding nutrition and skin health.
  • Formulate an approach to the use of cosmeceuticals and nutraceuticals in clinical dermatology practice.

Description

This forum will investigate the role of cosmeceuticals and nutraceuticals in clinical practice. It will present the most recent information on topical product formulation evaluating the use of stem cell derived ingredients, probiotics, and naturally sourced materials for persons of all Fitzpatrick skin types. This topical information will be paired with a discussion on the use of oral supplements purported to improve skin health. This session will survey the OTC market offerings that are frequently the source of patient questions. Participants are encouraged to bring questions for the expert panel to address.

Disclosures

  • Berson, Diane S., MD: Aclaris Therapeutics Inc. – C(H); Allergan, Inc – C(H); Bayer – A(H); Galderma Laboratories, L.P. – A(H); La Roche-Posay Laboratoire Pharmaceutique – A(H); Procter & Gamble Company – C(H); Revance Therapeutics, Inc. – A(H); Sienna Biopharmaceuticals – A(H); Sinclair Pharma – A(H); Skinfix, Inc. – A(H); Taro Pharm – A(H); TopMD – C(H);
  • Draelos, Zoe Diana, MD: Abbott Laboratories – I(Grants/Research Funding); Actavis – I(Grants/Research Funding); AGI Dermatics – I(Grants/Research Funding); Allergan, Inc. – I(Grants/Research Funding); AmDerma Pharmaceuticals, LLC – I(Grants/Research Funding); Amgen – I(Grants/Research Funding); Amneal Pharmaceuticals, LLC – I(Grants/Research Funding); AstraZeneca – I(Grants/Research Funding); Avon Products, Inc. – I(Grants/Research Funding); Bayer – I(Grants/Research Funding); Bayer Consumer Healthcare Pharmaceuticals – I(Grants/Research Funding); Beiersdorf, Inc. – I(Grants/Research Funding); Boots – C(Grants/Research Funding); Celgene Corporation – I(Grants/Research Funding); Chattem, Inc. – I(Grants/Research Funding); Colgate-Palmolive – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); Dial Corporation – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Elizabeth Arden – I(Grants/Research Funding); Exeltis – I(Grants/Research Funding); Galderma Laboratories, L.P. – I(Grants/Research Funding); GlaxoSmithKline – I(Grants/Research Funding); Glenmark Generics Inc. – I(Grants/Research Funding); Guthy-Renker – I(Grants/Research Funding); Helix BioMedix – I(Grants/Research Funding); Johnson & Johnson Consumer Products Company – I(Grants/Research Funding); Kao Brands – I(Grants/Research Funding); Kimberly Clark – I(Grants/Research Funding); Kythera – I(Grants/Research Funding); L'Oreal USA Inc. – I(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – I(Grants/Research Funding); Lexington International LLC – I(Grants/Research Funding); Living Proof, Inc – I(Grants/Research Funding); Lumity – I(Grants/Research Funding); MakuCell, Inc. – I(Grants/Research Funding); Maruho Co., Ltd – I(Grants/Research Funding); Medicis Pharmaceutical Corporation – I(Grants/Research Funding); Merck & Co., Inc. – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – I(Grants/Research Funding); Mimetica Pty. Limited – I(Grants/Research Funding); Neocutis – I(Grants/Research Funding); Neutrogena Corporation – I(Grants/Research Funding); Niadyne – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Nuskin – I(Grants/Research Funding); Oculus – I(Grants/Research Funding); Onset Therapeutics – I(Grants/Research Funding); Otsuka Pharmaceutical Co., Ltd. – I(Grants/Research Funding); Pacific Biosciences – I(Grants/Research Funding); Perrigo Company – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Procter & Gamble Company – I(Grants/Research Funding); Promius Pharma, LLC – I(Grants/Research Funding); Quinnova Pharmaceuticals, Inc. – I(Grants/Research Funding); Ranbaxy Laboratories Limited – I(Grants/Research Funding); RECKITT BENCKISER (ESPAÑA), S.L. – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Revision Skincare – I(Grants/Research Funding); Signum Biosciences, Inc. – I(Grants/Research Funding); SkinMedica, Inc. – I(Grants/Research Funding); Sun Products Corporation – I(Grants/Research Funding); Suneva Medical, Inc. – I(Grants/Research Funding); Symrise – I(Grants/Research Funding); Syneron, Inc. – I(Grants/Research Funding); Taro Pharm – I(Grants/Research Funding); Teva Pharmaceuticals USA – I(Grants/Research Funding); Tolmar – I(Grants/Research Funding); Valeant Pharmaceuticals International – I(Grants/Research Funding); Vichy Laboratoires – I(Grants/Research Funding);
  • Farris, Patricia, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc. – Speaker/Faculty Education(H); ISDIN – A(H); Johnson and Johnson Consumer Products Company – A(H); L'Oreal USA Inc. – A(H); La Roche-Posay Laboratorie Pharmaceutique – A(H); Nutraceutical Wellness, LLC. – A(SO); Regimen MD – F(ST); SkinCeauticals LLC – A(H); SkinMedica, Inc. – A(H);
  • McDaniel, David H., MD: Aesthetic Buyers Guide – A(NC); Allergan, Inc. – I(Grants/Research Funding); BTL Industries – I(EQ); Canfield Scientific, Inc. – I(Grants/Research Funding); Cynosure, Inc – A(H), I(EQ), I(Grants/Research Funding); Institute of Anti Aging Research – F(ST); Lifespan Extension – F(ST); Merz Pharmaceuticals, LLC – I(Grants/Research Funding); NorthCell – I(ST); Pfizer Inc. – I(Grants/Research Funding); PhotonMD, Inc. – C(SO), I(Grants/Research Funding); RegenX Science, Inc. – I(Grants/Research Funding); SkinBetter Science – C(Fees), I(Grants/Research Funding), SP(H); SkinCeauticals LLC – SP(H); ThermiRF/Almirall – I(Grants/Research Funding); Zalea, LLC – A(SO); Zeltiq Aesthetics – O(OB); Zimmer – I(EQ);
  • Taylor, Susan C., MD: Aclaris Therapeutics, Inc. – A(H), I(Grants/Research Funding), SP(H); Allergan, Inc – A(H), Speaker/Faculty Education(NC); Beiersdorf, Inc. – A(H), C(H); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Laboratories, LP – Speaker/Faculty Education(H); KGL Skin Study Center – Independent Contractor(S); Neostrata – C(H); Unilever – SP(H);
  • Zeichner, Joshua, MD: Allergan, Inc – A(H); Allergan, Inc. – Speaker/Faculty Education(H); Bayer Pharmaceuticals – Speaker/Faculty Education(H); Foamix – A(H); Galderma Laboratories, L.P. – C(H); Johnson & Johnson Consumer Products Company – C(H); La Roche-Posay Laboratorie Pharmaceutique – C(H); Pfizer Inc. – A(H), Speaker/Faculty Education(H); Promius Pharma, LLC – A(H); Regeneron – Speaker/Faculty Education(H); Valeant Pharmaceuticals International – A(H);
Schedule
Saturday, February 17
1:00 PM
Dr. Draelos / Plant vs. Animal Stem Cell Cosmeceuticals
1:20 PM
Dr. Farris / Oral and Topical Pre- and Pro-biotics
1:40 PM
Dr. Zeichner / The Reality of Natural Skin Care Products
2:00 PM
Dr. McDaniel / Techniques for Eating Yourself Young
2:20 PM
Dr. Taylor / Cosmeceutical Selection in Skin of Color
2:40 PM
Dr. Berson / Notable Cosmeceutical Ingredients 2018
Event Details
  • Date
    Saturday, February 17
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 28D
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers
  • David H. McDaniel, MD, FAAD
  • Diane S. Berson, MD, FAAD
  • Joshua Zeichner, MD, FAAD
  • Patricia Farris, MD, FAAD - Handout
  • Susan C. Taylor, MD, FAAD